Search details
1.
Boosting with variant-matched or historical mRNA vaccines protects against Omicron infection in mice.
Cell
; 185(9): 1572-1587.e11, 2022 04 28.
Article
in English
| MEDLINE | ID: mdl-35452622
2.
mRNA-1273 protects against SARS-CoV-2 beta infection in nonhuman primates.
Nat Immunol
; 22(10): 1306-1315, 2021 10.
Article
in English
| MEDLINE | ID: mdl-34417590
3.
Imprinting of serum neutralizing antibodies by Wuhan-1 mRNA vaccines.
Nature
; 2024 May 15.
Article
in English
| MEDLINE | ID: mdl-38749479
4.
SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness.
Nature
; 586(7830): 567-571, 2020 10.
Article
in English
| MEDLINE | ID: mdl-32756549
5.
Comprehensive evaluation of canonical versus Dicer-substrate siRNA in vitro and in vivo.
RNA
; 18(3): 557-68, 2012 Mar.
Article
in English
| MEDLINE | ID: mdl-22294662
6.
Intestinal helminth infection impairs vaccine-induced T cell responses and protection against SARS-CoV-2.
bioRxiv
; 2024 Jan 15.
Article
in English
| MEDLINE | ID: mdl-38293221
7.
Bivalent SARS-CoV-2 mRNA vaccines increase breadth of neutralization and protect against the BA.5 Omicron variant in mice.
Nat Med
; 29(1): 247-257, 2023 01.
Article
in English
| MEDLINE | ID: mdl-36265510
8.
Domain-based mRNA vaccines encoding spike protein N-terminal and receptor binding domains confer protection against SARS-CoV-2.
Sci Transl Med
; 15(713): eadf4100, 2023 09 13.
Article
in English
| MEDLINE | ID: mdl-37703353
9.
Transcriptional regulation by small RNAs at sequences downstream from 3' gene termini.
Nat Chem Biol
; 6(8): 621-9, 2010 Aug.
Article
in English
| MEDLINE | ID: mdl-20581822
10.
Rational Design and In Vivo Characterization of mRNA-Encoded Broadly Neutralizing Antibody Combinations against HIV-1.
Antibodies (Basel)
; 11(4)2022 Oct 24.
Article
in English
| MEDLINE | ID: mdl-36412833
11.
Altering the mRNA-1273 dosing interval impacts the kinetics, quality, and magnitude of immune responses in mice.
Front Immunol
; 13: 948335, 2022.
Article
in English
| MEDLINE | ID: mdl-36426367
12.
mRNA-1273 and Ad26.COV2.S vaccines protect against the B.1.621 variant of SARS-CoV-2.
Med
; 3(5): 309-324.e6, 2022 05 13.
Article
in English
| MEDLINE | ID: mdl-35584653
13.
Development of SARS-CoV-2 mRNA vaccines encoding spike N-terminal and receptor binding domains.
bioRxiv
; 2022 Oct 07.
Article
in English
| MEDLINE | ID: mdl-36238717
14.
Bivalent SARS-CoV-2 mRNA vaccines increase breadth of neutralization and protect against the BA.5 Omicron variant.
bioRxiv
; 2022 Sep 13.
Article
in English
| MEDLINE | ID: mdl-36263060
15.
Protective activity of mRNA vaccines against ancestral and variant SARS-CoV-2 strains.
Sci Transl Med
; 14(630): eabm3302, 2022 Feb 02.
Article
in English
| MEDLINE | ID: mdl-34846168
16.
Boosting with Omicron-matched or historical mRNA vaccines increases neutralizing antibody responses and protection against B.1.1.529 infection in mice.
bioRxiv
; 2022 Feb 09.
Article
in English
| MEDLINE | ID: mdl-35169795
17.
Distinct sensitivities to SARS-CoV-2 variants in vaccinated humans and mice.
Cell Rep
; 40(9): 111299, 2022 08 30.
Article
in English
| MEDLINE | ID: mdl-35988541
18.
Variant SARS-CoV-2 mRNA vaccines confer broad neutralization as primary or booster series in mice.
Vaccine
; 39(51): 7394-7400, 2021 12 17.
Article
in English
| MEDLINE | ID: mdl-34815117
19.
Variant SARS-CoV-2 mRNA vaccines confer broad neutralization as primary or booster series in mice.
bioRxiv
; 2021 Oct 07.
Article
in English
| MEDLINE | ID: mdl-33880468
20.
Protective activity of mRNA vaccines against ancestral and variant SARS-CoV-2 strains.
bioRxiv
; 2021 Aug 26.
Article
in English
| MEDLINE | ID: mdl-34462745